Provided by Tiger Trade Technology Pte. Ltd.

ZAI LAB

20.340
-0.360-1.74%
Volume:8.57M
Turnover:171.97M
Market Cap:23.15B
PE:-16.19
High:20.540
Open:20.540
Low:19.670
Close:20.700
52wk High:27.360
52wk Low:12.310
Shares:1.14B
HK Float Shares:1.14B
Volume Ratio:0.67
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.257
ROE:-26.91%
ROA:-14.75%
PB:4.86
PE(LYR):-16.19
PS:6.57

Loading ...

Hong Kong Stocks Close: Hang Seng Rises 0.54%, Tech Index Gains 0.78%, PCB Concept Shares Surge, Biotech Stocks Rally, Z.AI Jumps Over 14%

Deep News
·
Aug 07

Movement Alert|ZAI LAB Rises 15.9% in Regular Trading, Q2 Product Revenue Up 11% QoQ with Multiple H2 Catalysts Ahead

Market Focus
·
Aug 07

Hong Kong Market Movers: Innovative Drug Stocks Rally as Earnings Season Approaches, Medical Conferences Expected to Provide Catalysts

Stock News
·
Aug 07

Positive Catalysts Drive Surge in Innovative Drug Sector; WuXi Series Leads as Huabao's Hong Kong Stock Connect Medical ETF Jumps 3%

Deep News
·
Aug 07

Zai Lab's Hong Kong Shares Hit Three-Month High on Quarterly Revenue Beat

Reuters
·
Aug 07

Hong Kong Market Movers: Zai Lab Ltd (09688) Surges Over 13% on Q2 Product Revenue Growth and Promising Pipeline Catalysts

Stock News
·
Aug 07

Zai Lab Ltd 2026 Second Quarter Product Revenue Rises 11% Sequentially as Zoci and ZL-1503 Lead Global Pipeline Acceleration

Stock News
·
Aug 06

Zai Lab Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Zai Lab Q2 FY26 Net Loss Widens to $50.83 Million; Revenue Slips 3% to $106.31 Million Year over Year

Reuters
·
Aug 06

Zai Lab - Q2 2026 Net Loss $50.80 Mln, Loss Per Share $0.05, Loss Per Ads $0.46

THOMSON REUTERS
·
Aug 06

Zai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates

THOMSON REUTERS
·
Aug 06

Zai Lab - Q2 2026 Total Revenue $106.30 Mln vs $110 Mln in Q2 2025

THOMSON REUTERS
·
Aug 06

Zai Lab Reports Flat Share Count for July 2026; 1.14 B Issued Shares, No New Equity Raised

Bulletin Express
·
Aug 06

Zai Lab Says FDA Grants Orphan Drug Designation for DLL3 ADC Zocilurtatug Pelitecan in Neuroendocrine Carcinomas

Reuters
·
Aug 03

Earning Preview: ZAI LAB Q2 revenue expected to decline by 16.16%, institutions lean cautious on profitability trajectory

Earnings Agent
·
Jul 31

China's domestic innovative drugs set for overseas revenue breakthrough as policy support strengthens

Stock News
·
Jul 31

Asian Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading

MT Newswires Live
·
Jul 29

Zai Lab Sets 6 Aug Audit Committee Review and Immediate Release of 2026 Interim Results

Bulletin Express
·
Jul 24

Movement Alert|ZAI LAB Falls 5.05% in Regular Trading, Multiple Banks Cut Target Prices Amid Biotech Sector Weakness

Market Focus
·
Jul 24

Zai Lab Updates Financial Calendar with Upcoming Earnings Release and Conference Call

Reuters
·
Jul 22